Starsource Multitrade

Starsource Multitrade Cash & Equivalents

The Cash & Short-Term Investments of Starsource Multitrade (506365.BO) as of Nov 1, 2026 is 106.23 M INR. In the previous year, Cash & Short-Term Investments was 61.06 M INR — a change of 73.98% (higher).

Cash & Equivalents

106.23 MINR

YoY

73.98%

Last updated:

Cash & Short-Term Investments of Starsource Multitrade is 2025 106.23 M INR. Cash & Short-Term Investments of Starsource Multitrade was 2024 61.06 M INR. It decreases by 73.98% higher compared to the previous year.

The Starsource Multitrade Cash & Equivalents history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash & Equivalents
Date
Cash & Equivalents
Jan 1, 2023
60.56 M INR
Jan 1, 2024
61.06 M INR
Jan 1, 2025
106.23 M INR
The Starsource Multitrade Cash & Equivalents history
YEARCash & EquivalentsYoY
106.23 MINR+73.98%
61.06 MINR+0.82%
60.56 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Cash & Short-Term Investments of Starsource Multitrade is 106.23 M INR in 2025.

Cash & Short-Term Investments of Starsource Multitrade changed from 61.06 M INR to 106.23 M INR, representing a 73.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash & Short-Term Investments Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Cash and equivalents represent the most liquid assets on the balance sheet, available for immediate use or short-term obligations.

Cash & Short-Term Investments's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cash & Short-Term Investments's Starsource Multitrade historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Starsource Multitrade

All Key Metrics — Starsource Multitrade